EUVIMEDAtklāt EUVIMED
Crossref

Study on the anti‐cancer activity of α ‐phenethylamine ferrocenecarboxylic acid co‐crystals

Liao Youyin iD, Ma Yuexing, Chen Jiahao, Qian Kun, Yang Jie, Pan Rongbin, Xu Yiyong

Chirality · 2024

DOI: 10.1002/chir.23653 ↗

At a glance

Journal article in Chirality, 2024. Written by Liao Youyin and 6 co-authors. Institution: School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China. Major MEDLINE topics: Phenethylamines, Antineoplastic Agents, Ferrous Compounds. 25 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, Inherited and Innovative Group of Processing Technique of Traditional Chinese Medicine.

AbstraktsSubjectsBibliogrāfiskie datiCiteRelated studies

Abstract (original language)

Ferrocene derivatives show a wide range of pharmacological activities in the medical field, especially in the anti‐tumor field, and can be used as candidate drugs or lead compounds for the treatment of tumors and other diseases. And α ‐phenethylamine is an important intermediate for the preparation of fine chemical products. ( R )‐(+)‐1‐Phenethylamine ferrocenecarboxylic acid/( S )‐(−)‐1‐phenethylamine ferrocenecarboxylic acid were prepared, named compounds 1 and 2 , respectively. Single crystal X‐ray diffraction showed that compounds 1 and 2 crystallized in the orthorhombic system space group P 2 1 2 1 2 1 , and the crystal structures of compounds 1 and 2 exhibited mirror symmetry. The inhibitory effect of two compounds on SW480, MDA‐MB‐231, and H1299 cells was tested by MTT colorimetry. The IC 50 values of the compounds against cancer cells were also calculated. The anti‐cancer effect was more pronounced for compounds in the S ‐configuration. Compound 2 made the wild‐type cancer cells undergo apoptosis, thus preventing cancer; it also had the function of helping the cell gene repair defects.

Subjects

MeSH terms (MEDLINE)

PhenethylaminesAntineoplastic AgentsFerrous CompoundsMetallocenesCell Line, TumorStereoisomerism

Author keywords

cancer cellchiralityco-crystalferrocenecarboxylic acidphenethylamine

Substances

ferrocenecarboxylic acidMetallocenes1-phenethylaminePhenethylaminesAntineoplastic AgentsFerrous Compounds

Authors and institutions

  • School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.
  • School of Pharmacy, Nanchang Medical College, Nanchang, China.
  • Jiangxi Key Laboratory of Health and Drug Efficacy and Safety Evaluation, Nanchang Medical College, Nanchang, China.
  • Jiangzhong Cancer Research Center, Jiangxi University of Chinese Medicine, Nanchang, China.
  • School of Nursing, Jiangxi University of Chinese Medicine, Nanchang, China.

ORCID profiles: Liao Youyin

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangxi Province
  • Inherited and Innovative Group of Processing Technique of Traditional Chinese Medicine
  • Jiangxi Education Department Science Program

Cite

APA

Youyin, L., Yuexing, M., Jiahao, C., Kun, Q., Jie, Y., Rongbin, P., & Yiyong, X. (2024). Study on the anti‐cancer activity of α ‐phenethylamine ferrocenecarboxylic acid co‐crystals. Chirality. https://doi.org/10.1002/chir.23653

Vancouver

Youyin L, Yuexing M, Jiahao C, Kun Q, Jie Y, Rongbin P, et al. Study on the anti‐cancer activity of α ‐phenethylamine ferrocenecarboxylic acid co‐crystals. Chirality. 2024. doi:10.1002/chir.23653

BibTeX
@article{Youyin2024,
  author = {Youyin, Liao and Yuexing, Ma and Jiahao, Chen and Kun, Qian and Jie, Yang and Rongbin, Pan and Yiyong, Xu},
  title = {Study on the anti‐cancer activity of α ‐phenethylamine ferrocenecarboxylic acid co‐crystals},
  journal = {Chirality},
  year = {2024},
  doi = {10.1002/chir.23653}
}
Start for free →